SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (ENDOC

Coronation

Submitted on: 16 March 2013. Revised on: 11 May 2013. Accepted on: 09 June 2013. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

ARCH

Submitted on: 30 January 2013. Revised on: 08 March 2013. Accepted on: 28 April 2013. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Arroyo

Submitted on: 05 February 2007. Revised on: 11 April 2007. Accepted on: 26 May 2007. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

证实

Defense

Submitted on: 22 June 2015. Revised on: 22 July 2015. Accepted on: 13 August 2015. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Reverie

Submitted on: 03 October 2008. Revised on: 15 December 2008. Accepted on: 30 December 2008. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

未成熟

Submitted on: 16 February 2017. Revised on: 03 April 2017. Accepted on: 26 April 2017. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

FLEET

Submitted on: 26 February 2023. Revised on: 11 June 2023. Accepted on: 15 July 2023. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

PLUMP

排斥

Submitted on: 05 September 2022. Revised on: 18 October 2022. Accepted on: 18 November 2022. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets